KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Prepaid Assets: 2010-2025

Historic Prepaid Assets for Emergent BioSolutions (EBS) over the last 16 years, with Sep 2025 value amounting to $25.6 million.

  • Emergent BioSolutions' Prepaid Assets fell 58.03% to $25.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.6 million, marking a year-over-year decrease of 58.03%. This contributed to the annual value of $26.9 million for FY2024, which is 43.84% down from last year.
  • Emergent BioSolutions' Prepaid Assets amounted to $25.6 million in Q3 2025, which was up 6.67% from $24.0 million recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' Prepaid Assets ranged from a high of $139.9 million in Q3 2022 and a low of $24.0 million during Q2 2025.
  • Over the past 3 years, Emergent BioSolutions' median Prepaid Assets value was $36.5 million (recorded in 2024), while the average stood at $39.7 million.
  • In the last 5 years, Emergent BioSolutions' Prepaid Assets skyrocketed by 105.92% in 2021 and then tumbled by 64.35% in 2023.
  • Emergent BioSolutions' Prepaid Assets (Quarterly) stood at $70.2 million in 2021, then decreased by 17.52% to $57.9 million in 2022, then fell by 17.27% to $47.9 million in 2023, then slumped by 43.84% to $26.9 million in 2024, then crashed by 58.03% to $25.6 million in 2025.
  • Its last three reported values are $25.6 million in Q3 2025, $24.0 million for Q2 2025, and $30.2 million during Q1 2025.